Assyro AI

FDA Orange Book · active-ingredient family

Quinidine sulfate

Quinidine sulfate is approved as 1 brand and 47 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:QUINIDEX · NDA 012796

1

Brand (NDA)

47

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · capsule, tablet, tablet, extended release

ProductApplicantApplicationTEApproved
QUINIDEXWYETH PHARMS INCNDA 012796—Approved Prior to Jan 1, 1982

Generic (ANDA) products (47)

ProductApplicantApplicationTEApproved
QUINIDINE SULFATECOSETTEANDA 040045—Jun 30, 1994
QUINIDINE SULFATESUN PHARM INDUSTRIESANDA 081029—Apr 14, 1989
QUINIDINE SULFATESUN PHARM INDUSTRIESANDA 081030—Apr 14, 1989
QUINIDINE SULFATESUN PHARM INDUSTRIESANDA 081031—Apr 14, 1989
QUINIDINE SULFATECHARTWELL RXANDA 089839—Sep 29, 1988
QUINIDINE SULFATESUPERPHARMANDA 088973—Apr 10, 1985
QUINIDINE SULFATEVANGARDANDA 087909—Jul 13, 1982
QUINIDINE SULFATEUSL PHARMAANDA 087837—Apr 14, 1982
CIN-QUINSOLVAYANDA 085296—Approved Prior to Jan 1, 1982
CIN-QUINSOLVAYANDA 085297—Approved Prior to Jan 1, 1982
QUINIDINE SULFATELILLYANDA 085103—Approved Prior to Jan 1, 1982
CIN-QUINRLDSOLVAYANDA 085299—Approved Prior to Jan 1, 1982
CIN-QUINRLDSOLVAYANDA 084932—Approved Prior to Jan 1, 1982
CIN-QUINSOLVAYANDA 085298—Approved Prior to Jan 1, 1982
QUINIDINE SULFATEBARRANDA 084177—Approved Prior to Jan 1, 1982
QUINIDINE SULFATECHARTWELL MOLECULARANDA 083743—Approved Prior to Jan 1, 1982
QUINIDINE SULFATECONTRACT PHARMACALANDA 083808—Approved Prior to Jan 1, 1982
QUINIDINE SULFATECYCLEANDA 083640—Approved Prior to Jan 1, 1982
QUINIDINE SULFATECYCLEANDA 085632—Approved Prior to Jan 1, 1982
QUINIDINE SULFATEDAVA PHARMS INCANDA 087011—Approved Prior to Jan 1, 1982
QUINIDINE SULFATEELKINS SINNANDA 083622—Approved Prior to Jan 1, 1982
QUINIDINE SULFATE×2EPIC PHARMA LLCANDA 088072—Approved Prior to Jan 1, 1982
QUINIDINE SULFATEEVERYLIFEANDA 083439—Approved Prior to Jan 1, 1982
QUINIDINE SULFATEHALSEYANDA 083583—Approved Prior to Jan 1, 1982
QUINIDINE SULFATEHIKMAANDA 083862—Approved Prior to Jan 1, 1982
QUINIDINE SULFATEIMPAX LABSANDA 083347—Approved Prior to Jan 1, 1982
QUINIDINE SULFATEIVAX SUB TEVA PHARMSANDA 084549—Approved Prior to Jan 1, 1982
QUINIDINE SULFATEKING PHARMSANDA 085175—Approved Prior to Jan 1, 1982
QUINIDINE SULFATEKV PHARMANDA 085276—Approved Prior to Jan 1, 1982
QUINIDINE SULFATELEDERLEANDA 086176—Approved Prior to Jan 1, 1982
QUINIDINE SULFATELILLYANDA 085038—Approved Prior to Jan 1, 1982
QUINIDINE SULFATEPERRIGOANDA 085322—Approved Prior to Jan 1, 1982
QUINIDINE SULFATEPHARMAVITEANDA 084627—Approved Prior to Jan 1, 1982
QUINIDINE SULFATEPUREPAC PHARMANDA 084003—Approved Prior to Jan 1, 1982
QUINIDINE SULFATESANDOZANDA 084631—Approved Prior to Jan 1, 1982
QUINIDINE SULFATESANDOZANDA 084914—Approved Prior to Jan 1, 1982
QUINIDINE SULFATESCHERER LABSANDA 085068—Approved Prior to Jan 1, 1982
QUINIDINE SULFATEVALEANT PHARM INTLANDA 083393—Approved Prior to Jan 1, 1982
QUINIDINE SULFATEVINTAGE PHARMSANDA 083963—Approved Prior to Jan 1, 1982
QUINIDINE SULFATEWARNER CHILCOTTANDA 083879—Approved Prior to Jan 1, 1982
QUINIDINE SULFATEWATSON LABSANDA 085584—Approved Prior to Jan 1, 1982
QUINIDINE SULFATEWATSON LABSANDA 083288—Approved Prior to Jan 1, 1982
QUINIDINE SULFATEWATSON LABSANDA 085140—Approved Prior to Jan 1, 1982
QUINIDINE SULFATEWATSON LABSANDA 085583—Approved Prior to Jan 1, 1982
QUINIDINE SULFATEWHITEWORTH TOWN PLSNANDA 085444—Approved Prior to Jan 1, 1982
QUINORAKEY PHARMSANDA 083576—Approved Prior to Jan 1, 1982
QUINORARLDSCHERINGANDA 085222—Approved Prior to Jan 1, 1982

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Quinidine sulfate — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.

Book a Demo